Imara Submits Confidential Draft Registration Statement for Proposed Initial Public Offering
BOSTON--(BUSINESS WIRE)--Sep 13, 2019--
Imara Inc. today announced that it has previously confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (“Securities Act”). This announcement is being issued in accordance with Rule 135 under the Securities Act.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190913005048/en/
CONTACT: Imara Media Contact:
Ten Bridge Communications
email@example.comImara Company / Investor Contact:
KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: RESEARCH BIOTECHNOLOGY PHARMACEUTICAL HEALTH GENERAL HEALTH OTHER SCIENCE SCIENCE
SOURCE: Imara Inc.
Copyright Business Wire 2019.
PUB: 09/13/2019 07:00 AM/DISC: 09/13/2019 07:01 AM